Safe Harbor Statements All statements included in this press release other than statements of historical fact are forward-looking statements and may be identified by their use of words such as "believe," "may," "might," "could," "will," "aim," "estimate," "continue," "anticipate," "intend," "expect," "plan" and other similar terms. These forwardlooking statements are based on our current assumptions, expectations and estimates of future events and trends. Forward-looking statements are only predictions and ...

Safe Harbor Statements All statements included in this press release other than statements of historical fact are forward-looking statements and may be identified by their use of words such as "believe," "may," "might," "could," "will," "aim," "estimate," "continue," "anticipate," "intend," "expect," "plan" and other similar terms. These forwardlooking statements are based on our current assumptions, expectations and estimates of future events and trends. Forward-looking statements are only predictions and ...

Following the announcement, Globus Medical will hold a teleconference to discuss its performance with the investment community at 4:30 p.m. Eastern Time. Participants may access the conference call live via webcast on the Investors page of Globus Medical's website at https://www.investors.globusmedical.com/newsevents/events-webcasts. The audio archive will be available after the call on the Investor page of the Globus Medical website. Safe Harbor Statements Email: investors@globusmedical.com www.globusmedic ...

The research service features daily updates of the Zacks Rank and Zacks Industry Rank, full access to the Zacks #1 Rank List, Equity Research reports, and Premium stock screens, all of which will help you become a smarter, more confident investor. Based on their value, growth, and momentum characteristics, each stock is assigned a rating of A, B, C, D, or F. The better the score, the better chance the stock will outperform; an A is better than a B, a B is better than a C, and so on. While good value is impo ...

What's Driving the Outperformance? For the current fiscal year, Globus Medical is expected to post earnings of $2.82 per share on $2.48 billion in revenues. This represents a 21.55% change in EPS on a 57.96% change in revenues. For the next fiscal year, the company is expected to earn $3.32 per share on $2.65 billion in revenues. This represents a year-over-year change of 17.73% and 6.97%, respectively. Globus Medical may be at a 52-week high right now, but what might the future hold for the stock? A key as ...

Everyone has their own methods for finding great value opportunities, but our model includes pairing an impressive grade in the Value category of our Style Scores system with a strong Zacks Rank. The proven Zacks Rank puts an emphasis on earnings estimates and estimate revisions, while our Style Scores work to identify stocks with specific traits. Value investors are also interested in a number of tried-and-true valuation metrics that help show when a company is undervalued at its current share price levels ...

The research service features daily updates of the Zacks Rank and Zacks Industry Rank, full access to the Zacks #1 Rank List, Equity Research reports, and Premium stock screens, all of which will help you become a smarter, more confident investor. The Style Scores are broken down into four categories: Momentum Score How Style Scores Work with the Zacks Rank That's where the Style Scores come in. Stock to Watch: Globus Medical (GMED) What are the Zacks Style Scores? For value investors, it's all about findin ...

The research service features daily updates of the Zacks Rank and Zacks Industry Rank, full access to the Zacks #1 Rank List, Equity Research reports, and Premium stock screens, all of which will help you become a smarter, more confident investor. What are the Zacks Style Scores? Each stock is assigned a rating of A, B, C, D, or F based on their value, growth, and momentum characteristics. Just like in school, an A is better than a B, a B is better than a C, and so on -- that means the better the score, the ...

It has been about a month since the last earnings report for Globus Medical (GMED) . Shares have added about 7.4% in that time frame, outperforming the S&P 500. Will the recent positive trend continue leading up to its next earnings release, or is Globus Medical due for a pullback? Before we dive into how investors and analysts have reacted as of late, let's take a quick look at the most recent earnings report in order to get a better handle on the important catalysts. Globus Medical Q1 Earnings Surpass, Ma ...

Shares of Globus Medical (GMED) reached a new 52-week high of $67.37 on May 22 before closing the session marginally lower at $67.15. In the past year, this Zacks Rank #3 (Hold) stock has rallied 25.8% compared with the 12.1% growth of the industry and the S&P 500 composite's rise of 29.5%. Globus Medical has an expected 2024 sales growth rate of 57.8%. Earnings for the year are projected to increase by 20.7% compared with the industry's 13.3%. The company topped earnings estimates in each of the trailing f ...